≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See these related core endpoints for full statistics:

Frontotemporal dementia, wide, incl. Pick's disease

DOID Endpoint Browser

FTD_WIDE

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — F02.0*, F02.09*
  • Hospital discharge: ICD-9 — 3311
  • Hospital discharge: ICD-8 — 29011
  • Cause of death: ICD-10 — F02.0*, F02.09*
  • Cause of death: ICD-9 — 3311
  • Cause of death: ICD-8 — 29011

2 out of 7 registries used, show all original rules.

218

4. Check minimum number of events

None

218

5. Include endpoints

None

218

6. Filter based on genotype QC (FinnGen only)

218

Control definitions (FinnGen only)

Control exclude
F5_DEMENTIA, G6_ALZHEIMER, G6_AD_WIDE

Extra metadata

First used in FinnGen datafreeze
DF9

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 218 95 123
Unadjusted period prevalence (%) 0.04 0.03 0.05
Median age at first event (years) 69.55 70.01 69.20

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
187
Matched controls
1868
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F02.09*G31.0
ICD-10 Finland
Dementia in Pick's disease without information on additional symptoms
+∞
134.0
112
*
G31.0
ICD-10 Finland
Circumscribed brain atrophy
1287.3
85.7
77
*
F03
ICD-10 Finland
Unspecified dementia
166.6
57.7
58
5
N05AX08
ATC
risperidone; systemic
30.7
50.2
68
34
F02.09
ICD-10 Finland
Dementia in Pick's disease without information on additional symptoms
+∞
41.2
38
*
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
15.5
38.4
67
65
N05AH04
ATC
quetiapine; oral
11.2
37.6
80
117
N06DA02
ATC
donepezil; oral
199.0
32.9
33
*
TAB00
NOMESCO Finland
Lumbar puncture
19.8
30.7
47
31
N05AH03
ATC
olanzapine; systemic
20.0
29.6
45
29
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
11.6
28.9
57
68
N03AG01
ATC
valproic acid; systemic, rectal
17.0
28.4
46
35
XA800
NOMESCO Finland
Neuropsychological investigation
20.7
27.4
41
25
N06DX01
ATC
memantine; oral
70.9
26.9
30
5
P20
ICPC
Memory disturbance
7.6
24.9
65
122
P70
ICPC
Dementia
78.3
24.5
27
*
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
11.1
23.7
47
55
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
9.7
20.0
42
54
N05BA06
ATC
lorazepam; systemic, sublingual
12.5
19.7
36
35
N06DA03
ATC
rivastigmine; oral, transdermal
111.4
19.0
20
*
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
210.2
18.9
19
*
F06.7
ICD-10 Finland
Mild cognitive disorder
20.8
18.4
27
15
F0203, G310
ICD-10 Finland
NA
+∞
18.0
17
*
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
+∞
16.9
16
*
G30.1
ICD-10 Finland
Alzheimer disease with late onset
185.9
16.8
17
*
A28
ICPC
Limited function/disability NOS
4.4
15.5
65
201
F0204, G310
ICD-10 Finland
NA
+∞
14.8
14
*
F0200, G310
ICD-10 Finland
NA
+∞
13.7
13
*
N06AX11
ATC
mirtazapine; oral
3.5
13.1
80
331
N05BA04
ATC
oxazepam; oral
3.6
12.7
69
259
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
+∞
12.6
12
*
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
138.9
12.6
13
*
N06AB10
ATC
escitalopram; oral
4.5
12.4
47
129
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
5.6
11.7
35
74
F02.00
ICD-10 Finland
Dementia in Pick's disease without additional symptoms
+∞
11.6
11
*
IAB14
NOMESCO Finland
Geriatric psychiatry consultation
+∞
11.6
11
*
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
37.6
11.4
14
*
IGY02
NOMESCO Finland
Psychiatric monitoring contact
30.1
10.9
14
5
N06AX16
ATC
venlafaxine; oral
4.8
10.9
38
95
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
63.7
10.8
12
*
RT250
NOMESCO Finland
NA
116.3
10.5
11
*
IBZ07
NOMESCO Finland
Neurological assessment in psychiatry
+∞
10.5
10
*
R41.0
ICD-10 Finland
Disorientation, unspecified
9.3
10.4
21
25
SPAT1234
SPAT
Support of social functional capacity
7.5
10.3
24
36
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
5.6
10.2
30
62
N05AD01
ATC
haloperidol; systemic
12.3
9.8
17
15
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
58.1
9.8
11
*
R41.3
ICD-10 Finland
Other amnesia
11.6
9.5
17
16
SPAT1216
SPAT
Assessment of functional ability
3.4
9.5
50
179
F06.4
ICD-10 Finland
Organic anxiety disorder
+∞
9.4
9
*
G30.8
ICD-10 Finland
Other Alzheimer disease
+∞
9.4
9
*
F02.04
ICD-10 Finland
Dementia in Pick's disease other additional symptoms of mixed type
+∞
9.4
9
*
F0202, G310
ICD-10 Finland
NA
+∞
9.4
9
*
AA1AD
NOMESCO Finland
CT of head and brain
2.9
9.4
73
341
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
6.0
9.2
25
47
SPAT1245
SPAT
Provision of support and information to patient’s family members
7.5
9.1
21
31
G31.9
ICD-10 Finland
Degenerative disease of nervous system, unspecified
38.7
9.1
11
*
N03AX09
ATC
lamotrigine; oral
9.4
9.0
18
21
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
6.1
8.6
23
42
RT150
NOMESCO Finland
NA
94.1
8.5
9
*
N05CD07
ATC
temazepam; oral
3.4
8.5
43
150
F0201, G310
ICD-10 Finland
NA
+∞
8.4
8
*
P99
ICPC
Psychological disorders other
15.4
8.3
13
9
F32.9
ICD-10 Finland
Depressive episode, unspecified
4.3
8.3
31
83
N99
ICPC
Neurological disease other
23.2
8.1
11
5
F22.0
ICD-10 Finland
Delusional disorder
15.9
7.8
12
8
N05AX12
ATC
aripiprazole; systemic
15.9
7.8
12
8
P28
ICPC
Limited function/disability (P)
47.0
7.8
9
*
IGY99
NOMESCO Finland
Other psychiatric treatment contact
19.4
7.7
11
6
A04
ICPC
Weakness/tiredness general
3.4
7.6
38
131
N06AB04
ATC
citalopram; systemic
2.8
7.4
53
231
F05.9
ICD-10 Finland
Delirium, unspecified
7.8
7.4
16
22
G30.0
ICD-10 Finland
Alzheimer disease with early onset
+∞
7.3
7
*
F064, G310
ICD-10 Finland
NA
+∞
7.3
7
*
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
31.3
7.2
9
*
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
7.5
7.2
16
23
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
10.6
7.2
13
13
R53
ICD-10 Finland
Malaise and fatigue
2.8
7.1
52
229
P29
ICPC
Psychological sympt/compl other
7.7
6.9
15
21
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
41.6
6.8
8
*
N05BA01
ATC
diazepam; systemic, rectal
3.1
6.7
38
142
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
0.2
6.3
8
315
F060, G310
ICD-10 Finland
NA
+∞
6.3
6
*
F020, G310
ICD-10 Finland
NA
+∞
6.3
6
*
F06.32
ICD-10 Finland
Organic depression
+∞
6.3
6
*
F06.2
ICD-10 Finland
Organic delusional [schizophrenia-like] disorder
+∞
6.3
6
*
IGV01
NOMESCO Finland
Psychiatric network contact
+∞
6.3
6
*
F01.9
ICD-10 Finland
Vascular dementia, unspecified
27.7
6.3
8
*
-
ICD-10 Finland
NA
8.1
6.2
13
17
N06AX26
ATC
vortioxetine; oral
7.1
6.2
14
21
A06AD11
ATC
lactulose; oral
2.8
6.1
41
170
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.2
6.1
73
415
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
4.3
6.0
21
53

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
33
12
32.23
49.30
1.0
1.0
755.8
574.0
ng/l
—
24
6
32
12
31.08
47.27
1.0
1.0
256.8
243.4
ng/l
—
23
5
33
34
11.26
29.29
1.1
1.2
1.6
3.4
e6/l
1.72
25
27
32
34
10.86
27.77
1.1
1.3
120.1
100.2
e6/l
0.08
24
27
19
13
15.92
21.32
1.4
1.1
—
—
—
0
0
94
367
3.74
19.85
2.0
1.7
1341.1
1203.2
nmol/l
0.72
73
267
24
31
8.58
17.78
1.2
1.2
—
—
—
0
0
12
13
9.71
9.96
1.0
1.1
—
—
—
0
0
19
42
4.86
8.29
1.1
1.3
—
—
—
0
0
70
357
2.42
7.91
3.0
3.3
2.4
2.5
mmol/l
1.09
54
307
118
757
2.22
7.67
2.8
2.0
87.9
95.5
pmol/l
1.11
66
380
101
610
2.22
7.61
2.5
3.4
2.4
2.3
mmol/l
0.12
83
525
71
380
2.29
7.09
4.9
3.9
—
—
—
0
0
93
577
2.07
6.24
3.3
4.1
7.4
7.4
ph
0.24
12
116
75
460
1.96
4.99
1.8
1.6
20.1
20.9
nmol/l
0.19
67
379
24
533
0.38
4.96
2.9
3.5
—
—
—
0
0
61
359
1.97
4.52
5.2
4.5
1.0
1.0
kg/l
—
5
53
110
788
1.80
4.36
4.0
4.8
35.5
35.1
g/l
0.31
96
733
70
440
1.87
4.23
6.8
6.8
—
—
—
0
0
84
561
1.81
4.17
2.7
2.0
384.8
272.3
u/l
0.36
74
519
13
37
3.67
4.12
1.1
1.3
—
—
—
0
0
79
522
1.81
4.04
3.9
3.3
—
—
—
0
0
70
447
1.83
3.99
4.0
3.8
88.5
87.5
%
0.12
65
435
114
843
1.74
3.92
7.0
5.9
1.2
1.2
mmol/l
0.10
99
744
6
7
8.77
3.28
1.5
1.1
—
—
—
0
0
80
558
1.69
3.26
4.3
3.4
—
—
—
0
0
32
169
2.05
3.16
5.2
8.3
—
—
—
0
0
78
550
1.65
3.01
3.9
3.3
0.2
0.6
e6/l
1.40
61
418
17
71
2.51
2.88
2.1
3.1
4.0
4.3
pmol/l
—
10
64
27
478
0.50
2.87
4.9
3.8
—
—
—
0
0
15
59
2.66
2.85
4.2
3.6
—
—
—
0
0
38
595
0.56
2.67
3.5
4.2
—
—
—
0
0
28
152
1.97
2.57
4.3
3.4
—
—
—
0
0
145
1656
0.63
2.56
3.9
5.0
1.4
1.5
mmol/l
0.78
123
1480
6
12
5.11
2.42
1.5
1.1
—
—
—
0
0
5
155
0.31
2.39
2.0
4.1
—
0.2
—
0
53
5
8
6.36
2.38
2.6
1.3
—
—
—
0
0
42
618
0.60
2.27
3.1
4.1
5.6
9.2
mg/mmol
0.80
30
385
153
1317
1.54
2.23
31.6
22.2
330.3
331.5
g/l
0.83
146
1309
73
539
1.53
2.22
4.7
4.4
—
—
—
0
0
9
210
0.40
2.21
1.0
1.3
—
—
—
0
0
16
74
2.25
2.21
16.3
3.9
—
—
—
0
0
144
1230
1.50
2.12
5.5
3.9
14.2
15.0
pmol/l
3.28
129
1072
5
145
0.33
2.11
2.0
4.2
—
0.0
—
0
44
5
144
0.33
2.11
2.0
3.9
—
0.3
—
0
38
37
235
1.69
2.08
9.8
6.9
1.1
1.0
mmol/l
0.05
30
189
6
15
4.08
2.05
1.5
1.1
—
—
—
0
0
6
15
4.08
2.05
1.7
1.1
—
—
—
0
0
139
1184
1.48
2.03
5.3
4.6
—
—
—
0
0
40
582
0.62
2.03
2.7
3.3
31.5
164.3
mg/l
0.65
30
377
51
700
0.65
1.99
1.9
2.2
—
—
—
0
0
149
1666
0.67
1.99
3.9
5.1
4.6
4.5
mmol/l
0.51
126
1500
78
597
1.48
1.97
3.8
3.5
33.1
169.7
e6/l
0.70
58
471
6
16
3.82
1.95
1.7
1.1
—
—
—
0
0
6
16
3.82
1.95
1.5
1.1
—
—
—
0
0
6
16
3.82
1.95
1.7
1.1
—
—
—
0
0
143
1609
0.68
1.94
3.6
4.5
1.4
1.3
mmol/l
1.61
119
1429
154
1705
0.67
1.87
4.8
5.7
2.7
2.6
mmol/l
0.47
133
1528
62
461
1.48
1.79
3.2
2.1
3.2
3.2
mg/l
0.02
55
402
26
407
0.59
1.76
1.3
1.3
—
—
—
0
0
85
674
1.43
1.75
4.5
4.0
102.6
87.8
e6/l
0.11
63
506
30
189
1.68
1.74
3.5
2.4
7.9
8.8
ug/l
0.08
21
167
63
477
1.45
1.65
6.0
4.2
0.0
0.0
estimate
—
10
165
53
388
1.48
1.64
3.1
2.9
528.7
542.1
mosm/kgh2o
0.18
48
330
152
1669
0.71
1.52
4.9
5.2
6.2
6.1
mmol/l
0.39
135
1497
55
413
1.44
1.49
1.6
1.8
440.0
441.9
pmol/l
0.02
44
333
44
320
1.47
1.41
3.0
3.3
0.8
0.8
mmol/l
0.23
37
298
44
584
0.69
1.38
2.6
3.2
7.9
7.2
mmol/l
0.55
39
473
148
1622
0.73
1.35
6.1
6.8
40.0
40.9
mmol/mol
0.53
135
1486
18
107
1.74
1.30
4.9
7.0
26.1
24.8
mmol/l
0.78
18
107
0
33
0.00
1.17
0.0
2.7
—
60.6
—
0
33
0
35
0.00
1.16
0.0
2.6
—
—
—
0
0
0
35
0.00
1.16
0.0
1.3
—
—
—
0
0
152
1380
1.34
1.15
6.9
7.9
82.1
80.3
u/l
0.17
134
1281
5
21
2.41
1.09
5.4
2.7
—
—
—
0
0
6
124
0.47
1.08
2.3
2.5
—
—
—
0
0
18
269
0.64
1.01
1.3
1.3
18.2
46.7
iu/ml
—
6
95
0
29
0.00
0.98
0.0
4.4
—
1.1
—
0
23
0
32
0.00
0.96
0.0
2.5
—
4.6
—
0
32
97
844
1.27
0.95
5.0
4.0
0.0
0.0
estimate
0.00
11
176
9
154
0.57
0.92
1.4
1.5
—
—
—
0
0
20
136
1.52
0.90
11.5
4.2
—
—
—
0
0
98
863
1.25
0.85
5.0
4.0
0.0
0.0
estimate
—
10
168
97
854
1.24
0.84
6.0
5.4
0.0
0.0
estimate
0.00
11
176
12
73
1.68
0.83
2.4
2.1
42.1
36.8
g/l
—
6
63
98
866
1.24
0.82
4.8
5.8
1.7
2.0
e9/l
1.22
83
757
18
255
0.68
0.80
1.4
1.3
—
—
—
0
0
0
24
0.00
0.79
0.0
3.3
—
—
—
0
0
0
24
0.00
0.79
0.0
1.5
—
—
—
0
0
164
1539
1.26
0.76
6.5
4.7
2.7
2.0
mu/l
0.59
143
1349
40
493
0.77
0.76
2.2
2.9
351.1
7718.7
umol/l
2.21
27
403
20
274
0.70
0.75
2.0
1.9
—
—
—
0
0
9
55
1.66
0.74
9.2
11.3
—
—
—
0
0
99
883
1.22
0.74
6.2
5.8
0.2
0.2
e9/l
0.22
83
765
176
1668
1.29
0.73
20.8
16.4
32.9
25.6
mg/l
1.38
136
1341
111
1003
1.22
0.72
8.7
9.3
4.7
4.2
e9/l
1.01
92
868
26
197
1.36
0.70
1.8
1.6
—
—
—
0
0
152
1421
1.23
0.69
26.4
17.8
39.7
39.3
%
0.28
99
911
44
361
1.27
0.69
4.2
3.7
56.5
222.0
ng/l
2.21
39
309
95
849
1.21
0.68
4.8
5.6
0.6
0.6
e9/l
0.49
77
720
5
95
0.52
0.68
1.2
1.4
—
—
—
0
0
86
762
1.21
0.67
4.2
4.2
67.3
44.5
ng/l
0.23
63
594
18
245
0.71
0.66
1.4
1.3
1.8
14.7
u/ml
—
7
92
25
191
1.35
0.64
2.2
4.2
—
—
—
0
0
20
147
1.40
0.64
3.1
3.6
85.2
86.9
ng/l
0.04
13
129
95
856
1.19
0.61
4.9
5.6
0.0
0.0
e9/l
0.08
80
728
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
0
20
0.00
0.60
0.0
2.4
—
573.5
—
0
11
14
97
1.47
0.60
2.4
2.5
—
—
—
0
0
0
21
0.00
0.60
0.0
3.6
—
61.2
—
0
12
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
0
22
0.00
0.59
0.0
5.3
—
—
—
0
0
26
203
1.32
0.59
2.0
3.3
8.0
9.5
umol/l
0.21
21
180
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
0
23
0.00
0.58
0.0
3.9
—
—
—
0
0
171
1783
0.81
0.58
23.6
20.1
75.9
82.7
umol/l
3.19
171
1783
29
234
1.28
0.53
1.8
3.0
1.6
1.7
%
0.37
24
208
13
178
0.71
0.51
3.9
3.8
—
—
—
0
0
70
780
0.85
0.50
5.0
5.5
2.7
2.8
ug/l
0.05
58
685
7
45
1.57
0.49
1.3
3.4
—
—
—
0
0
21
164
1.31
0.49
1.1
1.4
—
—
—
0
0
7
47
1.51
0.48
2.6
3.8
—
—
—
0
0
106
980
1.16
0.48
4.7
6.5
10.5
11.7
umol/l
0.83
95
926
65
579
1.17
0.47
4.8
5.5
—
—
—
0
0
16
122
1.34
0.43
27.9
6.6
25.4
24.5
mmol/l
0.52
16
116
25
303
0.80
0.43
1.6
1.4
2.3
2.5
g/l
0.32
13
177
8
57
1.42
0.42
1.4
1.2
—
—
—
0
0
11
149
0.72
0.41
1.5
1.4
—
—
—
0
0
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
0
16
0.00
0.41
0.0
1.8
—
—
—
0
0
0
17
0.00
0.41
0.0
1.1
—
37323.6
—
0
11
0
17
0.00
0.41
0.0
2.0
—
0.8
—
0
7
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
0
18
0.00
0.40
0.0
1.5
—
—
—
0
0
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
5
37
1.36
0.37
1.2
2.3
—
—
—
0
0
12
156
0.76
0.36
6.7
3.9
—
—
—
0
0
19
232
0.80
0.36
1.2
1.3
—
—
—
0
0
37
326
1.16
0.31
1.5
2.4
11.4
13.0
umol/l
0.79
30
298
7
100
0.69
0.31
1.1
1.2
—
—
—
0
0
7
55
1.28
0.30
1.4
1.5
—
—
—
0
0
32
364
0.86
0.30
2.1
5.2
—
—
—
0
0
8
106
0.75
0.29
2.9
8.7
—
—
—
0
0
174
1785
0.88
0.29
11.8
11.6
23.2
24.7
u/l
0.76
161
1701
40
445
0.88
0.28
2.4
3.2
0.9
0.8
ug/l
0.09
32
309
71
660
1.11
0.27
3.3
2.7
89.6
155.0
ug/l
3.69
61
600
12
149
0.79
0.26
1.3
1.5
—
—
—
0
0
18
212
0.84
0.25
1.3
1.4
—
—
—
0
0
34
304
1.14
0.24
1.4
2.4
2.3
2.3
g/l
0.34
26
281
8
105
0.75
0.21
1.3
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
1.6
—
0
6
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
59.3
—
0
6
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
5443.4
—
0
5
84
797
1.09
0.21
5.0
5.8
60.1
58.1
%
0.73
76
738
17
145
1.19
0.21
2.1
2.2
—
—
—
0
0
78
823
0.92
0.21
5.6
10.2
1.1
1.3
inr
3.36
14
248
0
13
0.00
0.21
0.0
2.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
2.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
31478.5
—
0
8
129
1249
1.08
0.19
3.8
4.4
—
—
—
0
0
140
1360
1.08
0.19
26.8
20.8
14.0
13.9
%
0.20
132
1335
6
53
1.14
0.19
2.8
2.3
25.1
25.3
mmol/l
—
6
42
111
1074
1.07
0.16
7.8
4.8
7.1
6.9
mmol/l
0.43
98
1008
12
140
0.85
0.15
1.3
1.5
—
—
—
0
0
9
79
1.15
0.15
1.2
1.3
—
—
—
0
0
42
392
1.09
0.15
1.7
1.7
1.5
1.5
mg/l
0.03
31
308
180
1827
0.92
0.15
31.0
24.0
30.4
30.5
pg
0.11
172
1794
180
1827
0.92
0.15
31.1
24.1
7.0
6.8
e9/l
0.66
171
1758
180
1827
0.92
0.15
31.1
24.1
4.3
4.4
e12/l
3.07
171
1760
180
1827
0.92
0.15
31.2
24.2
130.7
134.5
g/l
2.57
172
1791
180
1827
0.92
0.15
31.0
24.0
91.9
91.7
fl
0.26
172
1794
53
560
0.93
0.14
2.5
2.5
—
—
—
0
0
181
1783
1.09
0.14
27.1
19.5
139.7
139.7
mmol/l
0.05
171
1733
180
1826
0.92
0.14
31.1
24.1
246.7
241.6
e9/l
0.42
171
1768
8
98
0.81
0.14
2.6
3.0
—
—
—
0
0
84
811
1.06
0.12
5.0
6.1
25.1
26.3
%
0.44
74
743
80
773
1.06
0.11
5.2
5.8
0.7
0.6
%
0.27
71
714
181
1788
1.07
0.11
26.1
19.7
4.0
4.0
mmol/l
1.08
171
1740
13
146
0.88
0.11
1.3
1.3
—
—
—
0
0
5
48
1.04
0.09
3.2
2.1
8.0
8.0
kpa
—
5
42
174
1723
1.05
0.07
17.9
15.5
—
—
—
0
0
18
168
1.08
0.06
2.1
2.7
67.2
66.6
g/l
0.13
11
153
81
794
1.03
0.05
5.1
5.8
2.8
2.7
%
0.10
72
731
81
799
1.02
0.03
5.2
6.1
8.7
8.9
%
0.27
71
742
80
792
1.02
0.01
8.4
10.7
0.0
0.0
e9/l
0.58
61
647
58
574
1.01
0.00
2.9
2.4
48.4
58.5
u/l
1.94
52
523
34
336
1.01
0.00
1.4
1.2
0.7
1.5
u/ml
—
9
87
127
1271
1.00
0.00
3.1
4.4
13.5
14.4
mm/h
0.26
112
1151
10
96
1.04
0.00
4.7
2.8
1.2
1.0
%
—
10
96
16
162
0.99
0.00
1.7
2.8
146.9
228.3
ng/l
0.73
16
143
0
7
0.00
0.00
0.0
5.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
9
92
0.98
0.00
1.4
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
40.0
—
0
6
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
17.3
—
0
6
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
5
54
0.92
0.00
1.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
11.1
—
0
6
5
55
0.91
0.00
1.2
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
5.9
—
45.8
—
0
8
0
5
0.00
-0.00
0.0
1.0
—
1473.0
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: FTD_WIDE – Frontotemporal dementia, wide, incl. Pick's disease

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).